Showing 621 - 640 results of 8,086 for search '(( significantly reported decrease ) OR ( significantly ((we decrease) OR (linear decrease)) ))', query time: 0.69s Refine Results
  1. 621
  2. 622
  3. 623
  4. 624

    The percentage of studies that resulted in insect death increased over time. by Craig D. Perl (3326880)

    Published 2025
    “…There was a significant decrease in the proportion of studies reporting just invasive handling (without death) over time (linear regression; t<sub>20,18</sub> = 4.00, p = 0.001, R<sup>2 </sup>= 0.44). …”
  5. 625
  6. 626
  7. 627
  8. 628
  9. 629
  10. 630
  11. 631
  12. 632
  13. 633
  14. 634
  15. 635
  16. 636

    Data from: <b>Selection and genetic variation in plasticity drive age-related decreases in among-individual behavioural correlations</b> by Chang Seok Han (21814121)

    Published 2025
    “…Our findings indicate that the magnitudes of both the positive among-individual and genetic correlations were maintained across nymph and young adult stages, but significantly decreased with age during adulthood. This decrease was due to both selection and genetic variation in age-related behavioural plasticity. …”
  17. 637
  18. 638
  19. 639

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”
  20. 640

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”